Ultragenyx Pharmaceutical Inc. buy Barclays PLC
Start price
24.11.25
/
50%
€28.40
Target price
24.11.26
€43.44
Performance (%)
-23.10%
Price
08:32
?
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -23.10%. This prediction currently runs until 24.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.172% | -7.172% |
| iShares Core DAX® | 1.014% | 2.699% |
| iShares Nasdaq 100 | -6.470% | -8.771% |
| iShares Nikkei 225® | -6.517% | -12.580% |
| iShares S&P 500 | -2.721% | -1.752% |
Comments by Barclays_PLC for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Barclays PLC from $81.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Barclays_PLC for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.71
29.04.26
29.04.26
€36.72
29.04.27
29.04.27
5.46%
08:32
08:32
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€45.20
06.08.24
06.08.24
€74.24
06.08.25
06.08.25
-48.67%
07.08.25
07.08.25